Radiology and Oncology (Jun 2017)

High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer

  • Ono Takashi,
  • Yabuuchi Tomonori,
  • Nakamura Tatsuya,
  • Kimura Kanako,
  • Azami Yusuke,
  • Hirose Katsumi,
  • Suzuki Motohisa,
  • Wada Hitoshi,
  • Kikuchi Yasuhiro,
  • Nemoto Kenji

DOI
https://doi.org/10.1515/raon-2017-0023
Journal volume & issue
Vol. 51, no. 3
pp. 324 – 330

Abstract

Read online

There have been few reports about high total dose hypofractionated proton beam therapy for central lung cancer. The aim of this study was to examine retrospectively the safety and efficacy of high total dose hypofractionated proton beam therapy for central lung cancer.

Keywords